In the Territory. The Parties shall report to the Alliance Steering Committee on all significant clinical and regulatory issues relating to the Product(s), and the Alliance Steering Committee shall make recommendations and provide strategic guidance with respect to such issues.
Appears in 4 contracts
Sources: Strategic Alliance Agreement (Bionumerik Pharmaceuticals Inc), Strategic Alliance Agreement (Bionumerik Pharmaceuticals Inc), Strategic Alliance Agreement (Bionumerik Pharmaceuticals Inc)